Use cases — stage 03
Ship
Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
135 stories across 9 vendors
Veeva Systems44
- 01Transforming content operations for 2x faster time to market
- 02Compliant conversational AI (chat) for improved accessibility
- 03Website analytics and patient insights via Ostro
- 04Smarter targeting to reach underserved patient populations
- 05Agile territory strategies to scale pre-commercial field teams
- 06Unified regulatory data/processes for cross-functional alignment
- 07Transformed patient experience with Vault Patient CRM
- 08Fast-track to agentic call reporting with Vault CRM
- 09Architecting the AI-ready enterprise
- 10Generating commercial evidence with agentic call reporting
- 11Clinical data "one-stop shop"
- 12Patient engagement and ROI with scalable eCOA
- 13Faster trial setup and shorter cycles with Veeva Clinical Data
- 14Reducing site and patient burden
- 15Streamlining clinical study training
- 16Unified clinical operations platform, efficiency/collaboration
- 17Passes inspection with no findings
- 18Standard site experience via Site Connect
- 19Selected Veeva Vault CRM (announcement
- 20Selected Veeva Vault CRM (announcement
- 21Selected Veeva Vault CRM (announcement
- 22Launch excellence with a connected ecosystem
- 23More effective key account management
- 24Connected data unlocks value across commercial planning/execution
- 25Accelerating time to diagnosis for ultra-rare diseases via Veeva Compass
- 26One platform across development; less time finding data
- 27Eliminating workarounds, streamlining collaboration
- 28Cross-functional data foundation for rapid growth
- 29Data foundation for process efficiency and scaling AI
- 30Uncovering critical signals to drive strategic action
- 31Scientific communication foundation for launch
- 32Risk-based, audit-ready training
- 33Unified digital validation for rapid manufacturing growth
- 34Efficiency and compliance with unified quality
- 35Digital-first quality at the heart of QC lab
- 36Scaling globally by harmonizing data with unified RIM
- 37Accelerating RIM deployment with an agile approach
- 38Increasing submissions efficiency with continuous publishing
- 39Gains efficiency with unified safety system
- 40Increasing efficiency by harmonizing data across functions
- 41Reducing case processing time/costs with in-house safety
- 42Operational excellence via deeper data understanding
- 43Connecting data on a single development platform for efficiency
- 44Tips for proactively managing MedTech Vault
Kneat20
- 01Digitized 7 validation processes globally across 27 sites; >50% cycle-time reduction, replaced 3 QMS systems
- 02Built a state-of-the-art digital validation program from the ground up
- 03Electronic logbooks; $500,000 in savings across validation use cases
- 04Harmonized global validation processes while maintaining site flexibility
- 05Accelerated validation timelines, enhanced data integrity
- 06Enabled a data-driven future via CSV digitalization
- 0720-25% cost savings, 30-40% cycle-time reduction in commissioning & qualification
- 08Digitalized validation across 25+ sites, 24/7 visibility
- 09Streamlined C&Q and CSV with Kneat + VEQTOR partnership
- 10Cut CAPA/change-control time in half, 40% savings on test-script execution
- 11Rolled out validation across European and North American operations
- 1288% time saving on URS
- 13Reduced validation labor hours by 65%
- 14Digitalized analytical instrument validation for "Lab of the Future"
- 15Digitized entire validation lifecycle; >100% productivity leap
- 16Improved productivity/compliance (Kneat customer since 2014
- 17Moved from paper-based to digital validation; gains in 5 months
- 18Digitized all validation processes; 50% cycle-time reduction
- 19Transitioned from paper-based to digital validation globally (video story, no dedicated text case-study URL surfaced
- 20Digitalized CQV processes using Kneat Gx (video story, no dedicated text case-study URL surfaced
Medidata19
- 01Data management transformation using Medidata's integrated product suite — (no dedicated case-study URL surfaced; featured on customer-testimonials page
- 02Strategic partnership to embed Medidata AI across the full trial lifecycle
- 03Deployed Medidata Study Build AI (Designer) to accelerate global oncology pipeline
- 04Replaced delayed site payments with Medidata Site Payments Managed Services
- 05Streamlined oncology trials on the Medidata platform (video case study
- 06Used Rave EDC to improve patient screening
- 07Gained precedent-setting FDA approval for a hybrid synthetic control arm in a Phase 3 glioblastoma trial
- 08Accelerated complex trial completion, superior patient/site experience
- 09Reimagined next-gen clinical trial innovation with Medidata AI-powered experiences
- 10Expanded collaboration for patient-centric studies
- 11Extended 15-year partnership by an additional five years
- 12Extended collaboration to improve patient centricity and trial efficiency
- 13Pharmacovigilance via Rave Safety Gateway (with EXTEDO
- 14Used Rave EDC + Rave RTSM to support adaptive trial design via custom functions
- 15Increased rare-disease trial site count by 50% with Acorn AI Intelligent Trials
- 16Fast-growing pharma used Medidata CTMS to work effectively with a resource-constrained team
- 17Used Acorn AI's commercial data management tech (STRATA + LUMEN Insights) for U.S. relaunch of SYLVANT — (referenced in search index, no single dedicated URL captured
- 18Long-time Medidata customer (since 2016), efficiencies bringing rare-disease medicines to patients — (referenced on customer-testimonials page, no dedicated URL
- 19Each appear as named quotes/testimonials on the customer-testimonials page without individual dedicated case-study URLs
Oracle12
- 01Elevated pharmacovigilance safety with Oracle Argus and Empirica; significant reduction in reporting time
- 02Enhancing efficiency and patient safety with the Oracle Argus platform; AI-driven optimization for drug development programs
- 03Gains more efficient operations using Oracle Argus — (URL not confirmed; title/snippet only
- 04Provides broader pharmacovigilance services after selecting Argus — (URL not confirmed
- 05Considers Oracle Argus the "gold standard" in safety — (URL not confirmed
- 06Spotlights a two-decade partnership with Oracle Argus — (URL not confirmed
- 07Greater/faster insight into product safety, improved productivity via Argus — (URL not confirmed
- 08Referenced as an Argus customer story — (URL not confirmed
- 09Trusts Oracle Argus for safety case management — (URL not confirmed
- 10Drives clinical operations efficiency with Oracle Siebel CTMS — (URL not confirmed
- 11Partners with Oracle Clinical One to deliver hybrid clinical trials — (URL not confirmed
- 12Named in Oracle Life Sciences customer-success search results; individual URLs/descriptions not confirmed in this pass
ArisGlobal11
- 01Realizing overall business improvements/efficiencies with LifeSphere CTMS
- 02Register enables compliance and regulatory tracking
- 03Adopted LifeSphere LitPro to automate literature search/monitoring
- 04Selected ArisGlobal's cloud drug safety database; submitted 33,000 cases to FDA within 2 months of signing
- 05Manages clinical and pharmacovigilance cases across 30+ countries
- 06Selected LifeSphere for SUSAR reporting
- 07Triages inbound adverse event reports (agXchange IRT integrated with Argus
- 08Partners with ArisGlobal to manage clinical trials
- 09Modernized safety operations with AI; 25% efficiency gains in PV case intake/processing
- 10Meets immediate and future needs with LifeSphere Clinical Systems — (URL not directly confirmed on arisglobal.com; found via FeaturedCustomers aggregator
- 11Embraces LifeSphere ("The Blueprint") for efficiency and accuracy — (title only, URL not confirmed
Unlearn.AI10
- 01Partnered on ALS Digital Twin Group database for Phase 1/2 trial design
- 02Assessed digital twins for variance reduction/sample-size savings in Alzheimer's Phase 2 trial (AAIC 2024 poster
- 03Digital twins as a new lens for interpreting biomarker trends (AD/PD Vienna 2025 presentation
- 04Accelerated Alzheimer's trials using generative ML disease-progression forecasts (AAIC 2024 poster
- 05Evaluated digital-twins methodology using completed Alzheimer's Phase 2 data (AAIC 2022 presentation
- 06Used digital twins in a Phase 2a trial to predict Alzheimer's progression (AD/PD Boston 2025
- 07Applied digital twins to improve confidence in early-stage ALS trials (2024 ALS/MND presentation
- 08Streamlined QRL-201 randomized control trial efficiency via digital twins (Nov 2024 Summit
- 09Incorporated digital twins into SOL-257 trial design for data-driven decisions
- 10Applied digital twins to single-arm trial exploratory analyses
ValGenesis8
- 01Launched ValGenesis iVal in 97 days; moved off paper; saved 20-25 hrs/week; recouped 50% of investment in 20 weeks
- 02Transformed continuous process verification (CPV) approach via ValGenesis iCPV
- 03Aligned ValGenesis with a new computer system validation (CSV) program; identified process improvements
- 04Transitioned from paper-based to digital validation during an ERP upgrade
- 05Eliminated legibility/data-accuracy concerns by adopting digital validation documentation
- 06Implemented standardized validation management; impressed FDA inspectors
- 07Cut CSV process steps 40%, validation cycle time down 25% via integrated processes — (URL not separately confirmed; referenced in ValGenesis blog/resource content
- 08Digital transformation journey toward full digitalization of validation processes — (URL not separately confirmed; referenced in ValGenesis blog/resource content
Generis6
- 01Migrated 900,000 regulatory documents from legacy Documentum to CARA, serving 85,000 users
- 02Consolidated 65 million documents (13 TB) across two repositories via CARA during ongoing archiving
- 03Unified 12 siloed systems (18 million documents) into one CARA instance for 85,000 users
- 04Integrated QMS, RIM, and safety processes on the CARA Life Sciences Platform
- 05German pharma (500 users) implemented CARA for unified data management since 2022
- 06Transitioned from legacy systems to CARA for improved UX across global operations (Pfizer also separately reported consolidating 4 legacy systems / 18M docs / 40,000 users
Saama5
- 01Agentic transformation bridging data governance and care delivery
- 02Centralized patient/site data for faster insights ("More Data, More Insights, More Progress"
- 03Centralized data across 40+ systems via Data Hub; 35% faster time to data discovery
- 04Smart Data Quality saved 20,000+ data-manager hours, reconciled 105M data points in 4 months
- 05Source-to-Submission (S2S) cut SDTM mapping time 25%, 70% auto-mapping accuracy